These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Increased Free Water in the Substantia Nigra in Asymptomatic LRRK2 G2019S Mutation Carriers. Zhang D; Zhou L; Shi Y; Liu J; Wei H; Tong Q; He H; Wu T Mov Disord; 2023 Jan; 38(1):138-142. PubMed ID: 36253640 [TBL] [Abstract][Full Text] [Related]
8. Prospective clinical and DaT-SPECT imaging in premotor Sierra M; Martínez-Rodríguez I; Sánchez-Juan P; González-Aramburu I; Jiménez-Alonso M; Sánchez-Rodríguez A; Berciano J; Banzo I; Infante J Neurology; 2017 Aug; 89(5):439-444. PubMed ID: 28679601 [TBL] [Abstract][Full Text] [Related]
9. Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation. Matikainen-Ankney BA; Kezunovic N; Mesias RE; Tian Y; Williams FM; Huntley GW; Benson DL J Neurosci; 2016 Jul; 36(27):7128-41. PubMed ID: 27383589 [TBL] [Abstract][Full Text] [Related]
13. Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 Juárez-Flores DL; González-Casacuberta I; Ezquerra M; Bañó M; Carmona-Pontaque F; Catalán-García M; Guitart-Mampel M; Rivero JJ; Tobias E; Milisenda JC; Tolosa E; Marti MJ; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G J Transl Med; 2018 Jun; 16(1):160. PubMed ID: 29884186 [TBL] [Abstract][Full Text] [Related]
14. Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study. Mestre TA; Pont-Sunyer C; Kausar F; Visanji NP; Ghate T; Connolly BS; Gasca-Salas C; Kern DS; Jain J; Slow EJ; Faust-Socher A; Kasten M; Wadia PM; Zadikoff C; Kumar P; de Bie RM; Thomsen T; Lang AE; Schüle B; Klein C; Tolosa E; Marras C Mov Disord; 2018 Jul; 33(6):960-965. PubMed ID: 29665080 [TBL] [Abstract][Full Text] [Related]
15. Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging. Walker MD; Volta M; Cataldi S; Dinelle K; Beccano-Kelly D; Munsie L; Kornelsen R; Mah C; Chou P; Co K; Khinda J; Mroczek M; Bergeron S; Yu K; Cao LP; Funk N; Ott T; Galter D; Riess O; Biskup S; Milnerwood AJ; Stoessl AJ; Farrer MJ; Sossi V J Parkinsons Dis; 2014; 4(3):483-98. PubMed ID: 25000966 [TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers. Vilas D; Shaw LM; Taylor P; Berg D; Brockmann K; Aasly J; Marras C; Pont-Sunyer C; Ríos J; Marek K; Tolosa E Mov Disord; 2016 Jun; 31(6):906-14. PubMed ID: 27041685 [TBL] [Abstract][Full Text] [Related]
17. The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies. Pont-Sunyer C; Tolosa E; Caspell-Garcia C; Coffey C; Alcalay RN; Chan P; Duda JE; Facheris M; Fernández-Santiago R; Marek K; Lomeña F; Marras C; Mondragon E; Saunders-Pullman R; Waro B; Mov Disord; 2017 May; 32(5):726-738. PubMed ID: 28370517 [TBL] [Abstract][Full Text] [Related]
18. Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers. Vilas D; Ispierto L; Álvarez R; Pont-Sunyer C; Martí MJ; Valldeoriola F; Compta Y; de Fabregues O; Hernández-Vara J; Puente V; Calopa M; Jaumà S; Campdelacreu J; Aguilar M; Quílez P; Casquero P; Lomeña F; Ríos J; Tolosa E Parkinsonism Relat Disord; 2015 Oct; 21(10):1170-6. PubMed ID: 26306001 [TBL] [Abstract][Full Text] [Related]
19. Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. Li X; Patel JC; Wang J; Avshalumov MV; Nicholson C; Buxbaum JD; Elder GA; Rice ME; Yue Z J Neurosci; 2010 Feb; 30(5):1788-97. PubMed ID: 20130188 [TBL] [Abstract][Full Text] [Related]
20. Age-related LRRK2 G2019S Mutation Impacts Microglial Dopaminergic Fiber Refinement and Synaptic Pruning Involved in Abnormal Behaviors. Zhang Q; Cheng X; Wu W; Yang S; You H; Ye Z; Liu N; Chen X; Pan X J Mol Neurosci; 2022 Mar; 72(3):527-543. PubMed ID: 34409578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]